Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advance in treatment of atherosclerosis: Key targets and plaque-positioned delivery strategies. | J Tissue Eng | 2022 | 35356091 | PubTator, text mining | PubMed |
| Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer. | Mol Cancer | 2022 | 35337361 | PubTator, text mining | PubMed |
| The molecular mechanism of METTL3 promoting the malignant progression of lung cancer. | Cancer Cell Int | 2022 | 35331234 | PubTator, text mining | PubMed |
| PRP4 Induces Epithelial-Mesenchymal Transition and Drug Resistance in Colon Cancer Cells via Activation of p53. | Int J Mol Sci | 2022 | 35328513 | PubTator, text mining | PubMed |
| Circular RNA ITCH: An Emerging Multifunctional Regulator. | Biomolecules | 2022 | 35327551 | PubTator, text mining | PubMed |
| Screening and Identification of Putative Long Non-Coding RNA in Childhood Obesity: Evaluation of Their Transcriptional Levels. | Biomedicines | 2022 | 35327332 | PubTator, text mining | PubMed |
| Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens. | Antibiotics (Basel) | 2022 | 35326819 | PubTator, text mining | PubMed |
| MicroRNA as a Potential Therapeutic Molecule in Cancer. | Cells | 2022 | 35326459 | PubTator, text mining | PubMed |
| Downregulation of miR-33a/b and miR-181a contributes to recurrent pregnancy loss by upregulating S1PR1 and repressing regulatory T cell differentiation. | Placenta | 2022 | 35325806 | PubTator, text mining | PubMed |
| NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma. | Front Oncol | 2022 | 35311097 | PubTator, text mining | PubMed |
| TRIB2 regulates the expression of miR‑33a‑5p through the ERK/c‑Fos pathway to affect the imatinib resistance of chronic myeloid leukemia cells. | Int J Oncol | 2022 | 35302171 | PubTator, text mining | PubMed |
| Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol-lowering treatments? | Eur J Clin Invest | 2022 | 35294778 | PubTator, text mining | PubMed |
| IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity. | Mol Ther | 2022 | 35292359 | PubTator, text mining | PubMed |
| Identification of Novel Key Genes and Pathways in Multiple Sclerosis Based on Weighted Gene Coexpression Network Analysis and Long Noncoding RNA-Associated Competing Endogenous RNA Network. | Oxid Med Cell Longev | 2022 | 35281467 | PubTator, text mining | PubMed |
| Transcriptional, epigenetic and metabolic signatures in cardiometabolic syndrome defined by extreme phenotypes. | Clin Epigenetics | 2022 | 35279219 | PubTator, text mining | PubMed |
| Epigenetic remodeling in heart failure with preserved ejection fraction. | Curr Opin Cardiol | 2022 | 35275888 | PubTator, text mining | PubMed |
| Role of GD3 Synthase ST8Sia I in Cancers. | Cancers (Basel) | 2022 | 35267607 | PubTator, text mining | PubMed |
| Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling. | J Exp Clin Cancer Res | 2022 | 35260193 | PubTator, text mining | PubMed |
| Targeting the cytoskeleton and extracellular matrix in cardiovascular disease drug discovery. | Expert Opin Drug Discov | 2022 | 35258387 | PubTator, text mining | PubMed |
| The Roles of Noncoding RNAs in the Development of Osteosarcoma Stem Cells and Potential Therapeutic Targets. | Front Cell Dev Biol | 2022 | 35252166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=29